B

Bonus Biogroup Ltd
TASE:BONS

Watchlist Manager
Bonus Biogroup Ltd
TASE:BONS
Watchlist
Price: 9.9 ILS 1.02% Market Closed
Market Cap: 121.1m ILS
Have any thoughts about
Bonus Biogroup Ltd?
Write Note

Bonus Biogroup Ltd
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Bonus Biogroup Ltd
Total Liabilities & Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
B
Bonus Biogroup Ltd
TASE:BONS
Total Liabilities & Equity
â‚Ş32m
CAGR 3-Years
-31%
CAGR 5-Years
29%
CAGR 10-Years
20%
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Total Liabilities & Equity
$34.1m
CAGR 3-Years
47%
CAGR 5-Years
31%
CAGR 10-Years
N/A
Kamada Ltd
NASDAQ:KMDA
Total Liabilities & Equity
$351.2m
CAGR 3-Years
17%
CAGR 5-Years
18%
CAGR 10-Years
11%
Enlivex Therapeutics Ltd
NASDAQ:ENLV
Total Liabilities & Equity
$31.9m
CAGR 3-Years
-31%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Urogen Pharma Ltd
NASDAQ:URGN
Total Liabilities & Equity
$301.9m
CAGR 3-Years
31%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Entera Bio Ltd
NASDAQ:ENTX
Total Liabilities & Equity
$7.7m
CAGR 3-Years
-36%
CAGR 5-Years
1%
CAGR 10-Years
N/A
No Stocks Found

Bonus Biogroup Ltd
Glance View

Market Cap
121.1m ILS
Industry
Biotechnology

Bonus Biogroup Ltd. is a biotechnology company engaging in the field of stem cells and tissue engineering. The firm is developing cell therapy products based on autologous and allogeneic bone implants that will enable efficient bone transplant and provide cellular-based bone replacement prosthetics for repairing bone lesions. The company is targeting a worldwide market for the treatment of major disorders such as bone and cartilage related arthritis, osteoporosis, and various types of bones and joint trauma such as hip fractures and knee injuries, among others. On April 29, 2012, Bonus Bio Group Ltd fully acquired Bonus Therapeutic Ltd.

BONS Intrinsic Value
0.41 ILS
Overvaluation 96%
Intrinsic Value
Price
B

See Also

What is Bonus Biogroup Ltd's Total Liabilities & Equity?
Total Liabilities & Equity
32m ILS

Based on the financial report for Jun 30, 2024, Bonus Biogroup Ltd's Total Liabilities & Equity amounts to 32m ILS.

What is Bonus Biogroup Ltd's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
20%

Over the last year, the Total Liabilities & Equity growth was -46%. The average annual Total Liabilities & Equity growth rates for Bonus Biogroup Ltd have been -31% over the past three years , 29% over the past five years , and 20% over the past ten years .

Back to Top